1,198 results on '"Ragni, Margaret V."'
Search Results
2. Lack of factor VIII detection in humans and dogs with an intron 22 inversion challenges hypothesis regarding inhibitor risk
3. Predictors of liver disease outcomes in individuals with hemophilia and HCV infection
4. Optimizing liver health before and after gene therapy for hemophilia A
5. Pregnancy loss in individuals with von Willebrand disease and unspecified mucocutaneous bleeding disorders: a multicenter cohort study
6. Innovations in RNA therapy for hemophilia
7. A review of the rationale for gene therapy for hemophilia A with inhibitors: one-shot tolerance and treatment?
8. Prevalence and risk factors for bleeding in hereditary hemorrhagic telangiectasia: a National Inpatient Sample study
9. Prophylaxis with a recombinant factor VIII Fc in hemophilia A: long-term follow-up on joint health, efficacy, and safety from phase 3 studies in children and adults
10. Long-term outcomes of prophylaxis with a recombinant factor VIII Fc or recombinant factor IX Fc in patients with hemophilia previously treated on demand
11. Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial
12. Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B
13. Managing surgery in hemophilia with recombinant factor VIII Fc and factor IX Fc: Data on safety and effectiveness from phase 3 pivotal studies
14. Defenestrated endothelium delays liver-directed gene transfer in hemophilia A mice
15. Postoperative bleeding complications in patients with hemophilia undergoing major orthopedic surgery: A prospective multicenter observational study
16. Whole-exome analysis of adolescents with low VWF and heavy menstrual bleeding identifies novel genetic associations
17. Hemophilia A (Factor VIII Deficiency)
18. Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort
19. Exploring the Complex Role of Coagulation Factor VIII in Chronic Liver Disease
20. The design of a Bayesian platform trial to prevent and eradicate inhibitors in patients with hemophilia
21. Hormones and thrombosis: risk across the reproductive years and beyond
22. Observational study of recombinant factor VIII-Fc, rFVIIIFc, in hemophilia A
23. Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B
24. Recombinant vs plasma-derived von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease
25. The spectrum and severity of bleeding in adolescents with low von Willebrand factor–associated heavy menstrual bleeding
26. Von Willebrand disease and gastrointestinal bleeding: A national inpatient sample study
27. Long-term clinical outcomes of prophylaxis with an rFVIIIFc or rFIXFc in adults aged ≥50 years with hemophilia A or B
28. Observational cohort study of long‐term outcomes of liver transplantation in haemophilia
29. Prevalence and correlates of thrombosis in adults with immune thrombocytopenia: An NIS study
30. Gene therapy in hemophilia A: a cost-effectiveness analysis
31. von Willebrand Disease: Differential Diagnosis and Diagnostic Approach to Specific Subtypes
32. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.
33. Bleeding Disorders: Diagnosis and Treatment of Hemorrhagic Complications in the Intensive Care Unit
34. Coagulopathy in Cirrhosis
35. Rapidly loading emicizumab without immunosuppression in acquired haemophilia
36. Feasibility of the Von Willebrand disease PREVENT trial
37. Blood volume–based von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease
38. Unfractionated heparin in acute chest syndrome: a pilot feasibility randomized controlled trial of unfractionated heparin vs. standard of care in acute chest syndrome
39. 160 - Coagulation Factor Deficiencies
40. Accurate, simple, and inexpensive assays to diagnose F8 gene inversion mutations in hemophilia A patients and carriers
41. Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States
42. Observational cohort study of long‐term outcomes of liver transplantation in haemophilia.
43. Valoctocogene roxaparvovec gene transfer in participants with HIV
44. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and funding
45. Hemophilia A subjects with an intron-22 gene inversion mutation show CD4+ T-effector responses to multiple epitopes in FVIII
46. Post hoc longitudinal assessment of efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B
47. Hepatic stellate cell–conditioned myeloid cells provide a novel therapy for prevention of factor VIII antibody formation in mice
48. Colaboradores
49. 160 - Deficiencias de los factores de coagulación
50. Venous thromboembolism in pregnant women with sickle cell disease: A retrospective database analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.